483 Livzon Group Fuzhou Fuxing Pharmaceutical Aug 2018

483 Livzon Group Fuzhou Fuxing Pharmaceutical Aug 2018

Santos Camara FDA, Nicole Knowlton FDA$119.00 - Available Now

FDA investigators audited the Livzon Group Fuzhou Fuxing Pharmaceutical - Fuzhou, China facility and issued inspectional observations (via FDA 483) on 03 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Aug 2018
  • Location: Fuzhou, China
  • FEI: 3006772356
Add To Cart